Intercept Pharmaceuticals has pulled obeticholic acid (Ocaliva) from the U.S. market as a treatment for primary biliary ...

Primary sclerosing cholangitis is a rare liver complication that can develop among people with inflammatory bowel disease. Early diagnosis can help, but there’s no cure.

Intercept Pharmaceuticals has voluntarily pulled Ocaliva (obeticholic acid) from the US market following a request from the ...

Ahead of New York Fashion Week, Gilead Sciences is strutting its marketing stuff to raise awareness of primary biliary ...

Intercept Pharmaceuticals, Inc., a wholly owned biopharmaceutical subsidiary of Alfasigma S.p.A., today announced its ...

Rhonda Pacheco, who oversaw Zepbound’s launch, will run Takeda’s U.S. business. Elsewhere, early data suggested Maze might ...

FDA arrives at its rejections for a variety of reasons, though typically due to concerns over safety, effectiveness, or a problem with manufacturing. Issues with efficacy may require new analyses or ...

Gilead Sciences (($GILD)) announced an update on their ongoing clinical study. Gilead Sciences is currently conducting a Phase 3 clinical study ...

Rheumatoid arthritis has traditionally been framed as a self-contained autoimmune disease confined to joints, yet mounting ...

SINGAPORE - Teenager Ryan Lim slipped into depression after a series of post-transplant infections in 2023.The Ahmad Ibrahim ...

David Maggs, 73, was sentenced to life imprisonment after he stabbed his 74-year-old wife Linda Maggs 15 times as she lay in ...